Expertise in
2
conditions

Marianne C. Nicolson

Aberdeen, SCT, GB 
Expertise in
2
conditions
Aberdeen, SCT, GB 

Overview

Marianne Nicolson practices practicing medicine in Aberdeen, United Kingdom.

Ms. Nicolson is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Mesothelioma, and Lung Metastases.

She is actively involved in clinical research, co-authoring 35 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Aberdeen, SCT, United Kingdom
Other Locations
St. Luke's Cancer Centre, Ashford And St. Peters' Hospitals, Oxford, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomised, Open-label Phase III Trial Evaluating the Addition of Denosumab to Standard First-line Anticancer Treatment in Advanced NSCLC
A Randomised, Open-label Phase III Trial Evaluating the Addition of Denosumab to Standard First-line Anticancer Treatment in Advanced NSCLC
Enrollment Status: Terminated
Publish Date: September 08, 2026
Intervention Type: Other, Drug
Study Phase: Phase 3
TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)
TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)
Enrollment Status: Active_not_recruiting
Publish Date: May 04, 2026
Phase 3 Open-label, Multicentre, Randomised Trial to Establish Safety & Efficacy of an EGF Cancer Vaccine in Inoperable, Stage IV Biomarker Positive,Wild Type EGF-R NSCLC Patients Eligible to Receive Standard Treatment and Supportive Care
Phase 3 Open-label, Multicentre, Randomised Trial to Establish Safety & Efficacy of an EGF Cancer Vaccine in Inoperable, Stage IV Biomarker Positive,Wild Type EGF-R NSCLC Patients Eligible to Receive Standard Treatment and Supportive Care
Enrollment Status: Terminated
Publish Date: September 10, 2019
Intervention Type: Biological
Study Phase: Phase 3
View 2 Less Clinical Trials

35 Total Publications

Olaparib maintenance versus placebo monotherapy in patients with advanced non-small cell lung cancer (PIN): A multicentre, randomised, controlled, phase 2 trial.
Olaparib maintenance versus placebo monotherapy in patients with advanced non-small cell lung cancer (PIN): A multicentre, randomised, controlled, phase 2 trial.
Journal: EClinicalMedicine
Published: February 06, 2022

Frequently Asked Questions about Marianne C. Nicolson

Is Marianne C. Nicolson a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?

MediFind is an objective health platform that identifies experts based on real-world data. Marianne C. Nicolson is classified as an Advanced expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Marianne C. Nicolson participate in research or clinical trials?

Yes. Marianne C. Nicolson has published 35 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Marianne C. Nicolson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Nicolson's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile